Kevin Cameron
Voorzitter bij CUTERA, INC.
Vermogen: 99 859 $ op 31-05-2024
Profiel
Kevin J.
Cameron is the founder of ProCure Treatment Centers, Inc. (founded in 2005) where he holds the title of Founding Director.
He is also the founder of Glass, Lewis & Co. LLC (founded in 2003) where he serves as Executive Chairman.
Additionally, he is the founder of Ionetix Corp.
(founded in 2009) and holds the title of Chairman & Chief Executive Officer.
Mr. Cameron is also the founder of Pylum Biosciences, Inc. Mr. Cameron's current job(s) include being the Executive Chairman at Cutera, Inc. since 2023, an Independent Director at AvidBiotics Corp.
since 2007, a Director at Xyphos Biosciences, Inc., and a Director at Global Helium Corp.
since 2023.
His former job(s) include being an Independent Director at Keryx Biopharmaceuticals, Inc. from 2007 to 2018, a Director at Reddy Ice Holdings, Inc. from 2008 to 2011, a Director at ECOtality, Inc. in 2012, an Independent Director at Knight Therapeutics, Inc., the General Counsel at NorthPoint Communications Group, Inc. from 1997 to 2001, the General Counsel at Moxi Digital, Inc. from 2001 to 2002, and an Attorney at Kellogg Huber Hansen Todd Evans & Figel PLLC.
Mr. Cameron's education includes an undergraduate degree from McGill University and a graduate degree from The University of Chicago.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GLOBAL HELIUM CORP
2.83% | 20-10-2023 | 1 349 440 ( 2.83% ) | 99 859 $ | 31-05-2024 |
CUTERA, INC.
-.--% | 23-05-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Kevin Cameron
| Bedrijven | Functie | Begin |
|---|---|---|
| CUTERA, INC. | Voorzitter | 01-07-2023 |
| GLOBAL HELIUM CORP. | Directeur/Bestuurslid | 07-09-2023 |
Glass, Lewis & Co. LLC
 Glass, Lewis & Co. LLC Investment ManagersFinance Glass, Lewis & Co. LLC (Glass Lewis) is an independent investment research firm headquartered in San Francisco, California. The firm was founded in 2003 by Kevin J. Cameron & Gregory P. Taxin. Glass Lewis provides investment research and advice on proxy votes to institutional investor and?publicly listed?companies. Their clients include pension plans, mutual funds, and asset managers. | Oprichter | 01-01-2003 |
ProCure Treatment Centers, Inc.
 ProCure Treatment Centers, Inc. Hospital/Nursing ManagementHealth Services ProCure Treatment Centers, Inc. develops cancer treatment centers. The firm is dedicated to improving the lives of patients with cancer by increasing access to proton therapy, an alternative to traditional radiation. It provides design, construction, financing, staffing, training, and day-to-day operations of world-class proton therapy centers. The company was founded by John Montgomery Cameron in 2005 and is headquartered in Somerset, NJ. | Oprichter | 01-01-2005 |
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Xyphos Biosciences, Inc. engages in biotechnology business. The firm’s novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new ways to mobilize and control immune cells to find and destroy specifically targeted cells throughout the body. The company was founded by David W. Martin, Jr. and James L. Knighton and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | - |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Oprichter | - |
Ionetix Corp.
 Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | Algemeen Directeur | 01-03-2011 |
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Directeur/Bestuurslid | 01-01-2007 |
Eerdere bekende functies van Kevin Cameron
| Bedrijven | Functie | Einde |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Directeur/Bestuurslid | 12-12-2018 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Kevin Cameron
| McGill University | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| NORTHPOINT COMMUNICATIONS GROUP INC. | Communications |
| KNIGHT THERAPEUTICS INC. | Health Technology |
| CUTERA, INC. | Health Technology |
| GLOBAL HELIUM CORP. | Process Industries |
| Bedrijven in privébezit | 11 |
|---|---|
Glass, Lewis & Co. LLC
Glass, Lewis & Co. LLC Investment ManagersFinance Glass, Lewis & Co. LLC (Glass Lewis) is an independent investment research firm headquartered in San Francisco, California. The firm was founded in 2003 by Kevin J. Cameron & Gregory P. Taxin. Glass Lewis provides investment research and advice on proxy votes to institutional investor and?publicly listed?companies. Their clients include pension plans, mutual funds, and asset managers. | Finance |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Kellogg Huber Hansen Todd Evans & Figel PLLC
 Kellogg Huber Hansen Todd Evans & Figel PLLC Miscellaneous Commercial ServicesCommercial Services Kellogg Huber Hansen Todd Evans & Figel PLLC is a law firm that specializes in complex trial and appellate litigation. The private company is based in Washington, DC. The company's attorneys have extensive experience representing both plaintiffs and defendants in trials and appeals. | Commercial Services |
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Health Technology |
Reddy Ice Holdings, Inc.
 Reddy Ice Holdings, Inc. Beverages: Non-AlcoholicConsumer Non-Durables Reddy Ice Holdings, Inc. engages in the manufacture and distribution of packaged ice products. Its products include traditional cubed iced, block ice, and ice calculator. It offers services such as direct store delivery, merchandising equipment, ice factory, emergency management, and industrial cleaning. The company was founded in 1927 and is headquartered in Dallas, TX. | Consumer Non-Durables |
Moxi Digital, Inc.
 Moxi Digital, Inc. Cable/Satellite TVConsumer Services Moxi Digital, Inc. provides cable and satellite television services. The company designs software and hardware for cable and satellite set-top boxes. It offers home entertainment solutions. Moxi Digital was founded by Steve Perlman in 2000 and is headquartered in Palo Alto, CA. | Consumer Services |
ECOtality, Inc.
 ECOtality, Inc. Electrical ProductsProducer Manufacturing ECOtality, Inc. developed electric power cell technology. The company filled a bankruptcy on September 16, 2013. It operates through four business segments: Fuel Cell Store, ECOtality North America, Innergy and International. The Fuel Cell Store segment is an online marketplace for fuel cell-related products and technologies with online distribution sites in the U.S., Japan, Russia, Italy and Portugal. The ECOtality North America segment involves in the research, development and testing of advanced transportation and energy systems with a focus on alternative-fuel, hybrid and electric vehicles and infrastructures. The Innergy segment provides unique power solutions including solar and battery pack manufacturing and assembly, and electric charging station assembly, repair and maintenance. The International segment markets and distributes its Blink and Minit-Charger equipment in Australia. The company was founded on April 21, 1999 and was headquartered in Phoenix, AZ. | Producer Manufacturing |
Ionetix Corp.
Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | Health Technology |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Health Technology |
Xyphos Biosciences, Inc.
Xyphos Biosciences, Inc. BiotechnologyHealth Technology Xyphos Biosciences, Inc. engages in biotechnology business. The firm’s novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new ways to mobilize and control immune cells to find and destroy specifically targeted cells throughout the body. The company was founded by David W. Martin, Jr. and James L. Knighton and is headquartered in South San Francisco, CA. | Health Technology |
ProCure Treatment Centers, Inc.
ProCure Treatment Centers, Inc. Hospital/Nursing ManagementHealth Services ProCure Treatment Centers, Inc. develops cancer treatment centers. The firm is dedicated to improving the lives of patients with cancer by increasing access to proton therapy, an alternative to traditional radiation. It provides design, construction, financing, staffing, training, and day-to-day operations of world-class proton therapy centers. The company was founded by John Montgomery Cameron in 2005 and is headquartered in Somerset, NJ. | Health Services |
